Berger David B's Form 4 filing
Tandem Diabetes Care Inc (TNDM) · filed Mar 21, 2022
- Accession no.
- 0001438133-22-000041
- Filed
- Mar 21, 2022
- Trade date
- Mar 16, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $541.9K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berger David BCIK 0001422126 | Officer (EVP & Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $18.86 | +$94,300 | 9,717 | Direct | |
| Mar 16, 2022 | Common Stock | SSaleDisposed | −5,000 | $108.37 | −$541,850 | 4,717 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $18.86 | +$94,300 | 43,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.